Whistleblower responsible for case against Novo?
Novo Nordisk CFO Jesper Brandgaard revealed how the Danish company views a US DA’s critical interest in its Danish production facilities, as Novo reported Q3 earnings last week.
BY STEFAN SINGH KAILAY
It might be a whistleblower in the US who aroused a Massachusetts DA’s interest in certain parts of Novo Nordisk’s production facilities in the Danish town Kalundborg, CFO Jesper Brandgaard said last week in connection with the Danish diabetes giants reported Q3 earnings.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
DA scrutinizes Novo’s Kalundborg site
For abonnenter
Novo Nordisk post USD 100m in new plant
For abonnenter
Novo invests heavily in Danish manufacturing
For abonnenter
